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Background: Mortality and morbidity due to cardiovascular diseases (CVDs) are escalating worldwide, 
with disproportionately significant worse outcomes in developing countries, due to rapid health and nutrition 
transition resulting from unplanned urbanization, negative effects of globalization and sedentary lifestyles. 
Despite the growing trends of CVDs cases in hospital settings especially in Tanzania, still no study has been 
conducted to evaluate CVD risk factors among patients attending cardiac clinics, to see how they respond 
to current treatment. This study aimed at assessing lifestyle risk factors and biomarkers associated with 
hypertension and coronary heart diseases among patients attending cardiac clinics at Kilimanjaro Christian 
Medical Centre referral hospital in Tanzania. 
Methods: This was a cross-sectional hospital-based study conducted to determine the prevalence of lifestyle 
and intermediate risk factors for hypertension and coronary heart disease among patients with hypertension 
and coronary heart diseases who attended the cardiac clinic at Kilimanjaro Christian Medical Centre referral 
hospital between April to July 2008. Information on socio-demographic characteristics, medical condition 
and lifestyle risk factors for hypertension and coronary heart diseases were collected using a structured 
questionnaire. Blood samples were collected from each patient and analyzed by Cobas Integra and Maglumi 
analyzers, to detect and quantify important biomarkers. Descriptive statistics were used to analyze socio-
demographic, lifestyle risk factors and biomarkers for hypertension and coronary heart diseases. Pearson’s 
chi-square (χ2) tests were used to associate risk factors for hypertension and coronary heart diseases, and 
multinomial logistic regression was used to determine independent predictors for hypertension and coronary 
heart diseases. 
Results: Of the 100 patients recruited to participate in the study, 65% had hypertension, 23% had coronary 
heart diseases and 12% had both disease conditions. The most prevalent risk factors for hypertension and 
coronary heart diseases were: alcohol intake (67%), high blood pressure (59%), physical inactivity (61%), 
obesity (39%), alanine aminotransferase (43%), high-density lipoprotein (79%), low-density lipoprotein 
(65%), C-reactive protein (78%), sodium (41%) and potassium (40%). Moreover, age, plasma glucose, 
alanine aminotransferase, and C-reactive protein were found to be independently and positively associated 
with hypertension and coronary heart diseases. 
Conclusions: This study affirmed the exposure of patients to cardiovascular risk factors, despite being 
under medical management. These findings call for sensitization programs and additional interventions in 
the management of CVDs among patients attending cardiac clinics in Tanzania hospitals, to include health 
education on lifestyle risk factors modification and proper dietary habits. 
Original Article
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Introduction
Mortality and morbidity rates due to cardiovascular diseases 
(CVDs) are escalating worldwide, with disproportionately 
significant worse outcomes in the developing countries, 
due to rapid health and nutrition transitions caused by 
urbanization and globalization. More than 17.92 million 
people died in 2015 due to CVDs, with the highest death 
rate of 9.4 million recorded in men than 8.5 million in 
women (1,2). Coronary heart disease (CHD) ranks as the 
highest cause of deaths among all CVDs, accounting for 
more than 8.9 million deaths worldwide (3). The prevalence 
of CHD is increasingly uneven in different regions of 
the world, due to inadequate and lack of better health 
services (4). CHD is considered as a single cause of 
mortality and morbidity across all gender groups in 
developed and developing countries (4). Moreover, CHD 
was previously not given enough intervention priority in 
many countries from the Sub-Saharan region, due to lack 
of strong epidemiological studies that would determine 
true burden of disease (5,6). Findings from the recent 
[2008–2013] studies predicted that the growing burden of 
CHD in the region will exceed that observed in other world 
regions if no appropriate preventive measures will be taken 
to alleviate the problem (7). Similarly, hypertension (HTN) 
and HTN-related diseases are increasing the number of 
inpatients and outpatients in referral hospitals in Tanzania, 
posing healthcare challenges in primary and secondary 
healthcare, due to inadequate resources for their treatment 
and management (8,9). 
The growing CHD mortality rate is exacerbated by 
the increased levels of blood pressure and other CVD 
risk factors. HTN is one of the leading risks for global 
mortality, accounting for 13% of the total deaths (10), and is 
attributing to more than 45% of all CHD deaths and 51% 
deaths due to stoke worldwide (11). Untreated HTN results 
in more health complications, such as myocardial infarction 
(MI), renal diseases, stroke, heart failure and premature 
deaths (11). Treatment of blood pressure has been associated 
with more than 40% and 16% reduction of stroke and 
MI risk factors, respectively (12). The ultimate goal of 
managing HTN is to achieve target control and prevent the 
development of other HTN-related complications (13).
The management of HTN and HTN-related diseases, 
including CHD, usually varies from one country to another, 
as it depends on the capacity of the country to utilize 
the available resource for prevention and control of the 
diseases (14). For example, lowering of blood pressure 
together with the reduction of other CVD risk factors has 
been associated with 50% reduction of CVD mortality in 
some of the high-income countries (15). As a rule of thumb, 
the World Health Organization and the International 
Society of Hypertension recommend management of 
HTN by monitoring other CVD risk factors, patient-
centered lifestyle modification, damage organ and their 
related clinical signs (14,16), rather than relying on taking 
blood pressure measurement alone. Factors that need to be 
monitored during management includes levels of systolic 
and diastolic blood pressure, gender, age, smoking, blood 
cholesterol, history of CVD, obesity, physical activity, and 
diabetes. 
Lifestyle modification is one of the components of HTN 
management. Modifiable lifestyle risk factors, despite 
effectively delaying or preventing the onset of HTN, they 
also contribute to the reduction of blood pressure in patients 
with HTN and sometimes they may reduce the need for 
antihypertensive therapy (17,18). There is strong evidence 
of regular physical activity and protection against HTN (18). 
Regular physical activity is associated with a reduction of 
3.2 and 2.7 mmHg systolic and diastolic blood pressure, 
respectively. However, for patients with poorly controlled 
HTN (systolic ≥180 mmHg and diastolic ≥100 mmHg), 
physical exercise should be suspended until their blood 
pressure stabilized (17,18). It is also recommended to 
engage in any physical exercise rather than none. On the 
other hand, weight reduction is associated with a reduction 
in blood pressure, blood sugar, and reduced CVD risks (19). 
Evidence from meta-analysis showed that reduction of 
5.1 kg of body weight by means of energy restriction and 
increased physical activity reduces systolic and diastolic 
blood pressure by 4.4 and 3.6 mmHg, respectively (20). Diet 
modification that emphasizes on adequate intake of fruits 
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and vegetables, whole grains, low dietary fats, low intake 
of dietary sodium and salt reduction has shown a positive 
impact in the reduction of blood pressure in normotensive 
and hypertensive patients (17,21).  
Furthermore, inflammatory biomarkers for CVD 
such as lipids, high-sensitive C-reactive protein (CRP) 
and troponins play an important role in the diagnosis, 
monitoring of diseases progression, and decision making 
regarding the management of cardiovascular events (22,23). 
For example, CRP has been used to assess CVD risks, heart 
attack, stroke (23) and it has been identified as a single 
predictor of the risk of CVD events (24).
Despite the growing trends of CVD cases in a hospital 
setting in Tanzania, their management is only based on 
measurements of a few intermediate risk factors. Up to 
date, no study had been conducted in Tanzanian hospital 
settings to evaluate CVD risk factors among patients 
attending cardiac clinics, to see how they respond to current 
treatment. Therefore, this study was carried out to quantify 
lifestyle risk factors and biomarkers associated with HTN 
and CHD among patients attending cardiac clinics at 
Kilimanjaro Christian Medical Centre (KCMC) referral 
hospital in Kilimanjaro region-Tanzania. 
Methods
Study settings
This study was conducted at KCMC located in Kilimanjaro 
region-Tanzania. KCMC is a referral hospital which serves 
for over 15 million people in the northern, eastern and 
central zone of Tanzania. The hospital has a capacity to 
serve for 500–800 inpatients per day.
Study design and sampling method 
This was a cross-sectional hospital-based study to determine 
the prevalence of lifestyle risk factors among CVD patients 
attending the cardiac clinic at KCMC referral hospital. The 
study was conducted between April and July 2018. The 
purposeful sampling method was employed to select all 
patients who met the study selection criteria. 
Inclusion and exclusion criteria
Inclusion criteria
Adults aged ≥35 years diagnosed with CHD and HTN 
who attended the Cardiac clinic at KCMC referral hospital 
from April to July 2018. The study participants voluntarily 
consented to participate in the study. 
Exclusion criteria were
Children (including those with congenital heart diseases), 
pregnant women and patients with CHD and HTN 
aged ≥35 years who did not consent to take part in the 
study. 
Assessment of socio-demographic characteristics and 
lifestyle risk factors 
A structured questionnaire with closed questions was 
adopted from the WHO STEPwise survey (25) and 
translated to Kiswahili language (national language). The 
questionnaire was then administered to all participants. The 
following information was collected: socio-demographic 
information, lifestyle risk factors and family history of HTN 
and CHD. The assessed socio-demographic characteristics 
were: age, gender, marital status, and education level and 
occupation status. Education level was categorized as 
primary level, secondary level, higher education learning 
and uneducated. Marital status (married and no partners), 
occupation (formal employment, self-employed and 
unemployed). Lifestyle risk factors included current/history 
of smoking for the past 5 years (categorized as smoker 
or non-smoker), history of alcohol use (categorized as 
current alcohol user or non-alcoholic user), physical activity 
(categorized as physical exercise at least 2 days per week 
minimum for 30 minutes or no physical activity), and family 
history of either HTN or CHD (defined as having at least 
close relative (father, mother, sister or brother) diagnosed 
with ether HTN/CHD or both HTN and CHD). 
Anthropometric measurements 
Weight in kilogram was taken in light clothing by using 
calibrated weighing scale machine (Seca, Germany), with 
150 kg capacity and the accuracy of 0.5 kg. The patient was 
requested to remain with minimal clothes, remove shoes 
and excess weight in the pockets before measurements 
were taken. Height was measured in centimeter (cm) by 
calibrated stadiometer (Leicester stadiometer) of 0.1 cm 
accuracy, with the subject standing against the vertical 
wall, heels together, shoulders and head touching the wall 
surface and after removal of shoes. Body mass index (BMI) 
was then calculated by the following formula [BMI = 
weight (kg)/height (m2)].  BMI was categorized as 
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underweight (<18.5), normal (18.5–24.9), overweight 
(25.0–29.9) and obese (≥30.0) (26). 
Blood pressure measurements
Blood pressure measurement was conducted by the trained 
clinical officer upon arrival of the patient and after resting for 
10–15 minutes. Automatic digital sphygmomanometer with 
automatic inflation (Life Brand™ BM60) was used to measure 
blood pressure while the patient seated and relaxed with the 
left hand at the level of the heart. Three systolic and diastolic 
blood pressure readings were taken on the left upper arm 
of the patient. Average systolic and diastolic blood pressure 
was used in the analysis. Systolic and diastolic blood pressure 
measurements were used to classify HTN in accordance with 
the Seventh Joint National Committee (27) (Table 1). 
Blood sample collection 
Blood samples for plasma glucose, serum ALT, CRP, 
high-density lipoprotein cholesterol (HDL-C), and low-
density lipoprotein cholesterol (LDL-C) concentration 
measurements were obtained by a trained clinician. 
For each patient, 10 mL of venous blood samples 
were drawn from the arm and transferred to EDTA 
(ethylenediaminetetraacetic acid) tube. Blood samples 
were then taken to a clinical research laboratory at KCMC 
referral hospital for further analysis procedures. Blood 
samples were centrifuged at the 3,000-rpm machine (Roche 
Germany) for 5 minutes at 4 ℃. Clarified serum and plasma 
samples were then pipetted and poured into Eppendorf 
storage tubes (5 mL), followed by freezing at −20 ℃. 
Analysis of biomarkers
Before analysis, plasma and serum blood samples were 
mixed thoroughly by using vortex mixer. Form each sample, 
10 µL was pipetted and poured into Microvatte tubes. 
Plasma blood glucose, HLD-C, LDL-C, and ALT samples 
were loaded into Cobas Integra 400 plus analyzer (Roche 
Diagnostics, Germany). Serum blood for measuring CRP 
concentration was loaded into fully-auto chemiluminescence 
immunoassay (CLIA) analyzer (MAGLUMI 800), Shenzhen 
New Industries Biomedical Engineering Co., Ltd. (Snibe 
Diagnostic, China). According to laboratory protocols, 
values (concentrations) of studied biochemistry markers 
were categorized as indicated in Table 2. 
Statistical analysis 
Data were entered into Microsoft Excel 2013, then 
sorted, coded, and cleaned. The analysis was done using 
SPSS version 20.0 (IBM). Descriptive statistics were 
used to analyze the frequency and percentages of socio-
demographics, lifestyle characteristics, and biomarkers for 
HTN and CHD. Pearson’s chi-square (χ2) test was used to 
determine the association between risk factors with HTN 
and CHDs. Independent variables included in the analysis 
were: gender, age, education level, occupation, marital 
status, BMI, blood pressure, physical activity, smoking 
history, alcohol consumption, plasma blood sugar, ALT, 
HDL-C, LDL-C, and CRP levels. Independent variables 
significantly associated with HTN and CHD in chi-square 
(χ2) test were subjected to a multinomial logistic regression 
model to reveal independent predictors of HTN and CHD. 
Statistical significance was tested at 95% confidence interval 
(95% CI) (alpha ≤0.05). 
Results 
General characteristics of the study population 
The study recruited 100 patients of which 31% and 69% 
were men and women, respectively. 
More than three-quarter (81%) of the patients were 
within the age category of 45 years and above, while only 
19% were below 45 years. Nearly half (45%) of all patients 
Table 1 Blood pressure classification for adults according to the Seventh Joint National Committee
Classification Systolic BP (mmHg) Diastolic BP (mmHg)
Normal <120 <80
Pre-hypertension 120–139 80–89
Hypertension stage I 140–159 90–99
Hypertension stage II ≥160 ≥100
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had attained primary education while only 9% had no 
formal education. More than two-third of the patients were 
married and 72% were self-employed. More than half (53%) 
of the patients had a family history of HTN and CHDs. 
Further, 65% of patients were clinically diagnosed with 
HTN, whereas 23% of patients were diagnosed with CHD 
and 12% had both conditions (Table 3).
Proportions of lifestyles risk factors and biomarkers for 
HTN and CHDs
The proportion of lifestyle risk factors and biomarkers for 
HTN and CHDs were assessed for each patient involved 
in the study and results are summarized in Figure 1. Among 
the lifestyle risk factors assessed in this study, history 
of current alcohol (22% of males and 45% of females) 
consumption ranked the highest, followed by physical 
inactivity for female than male patients (40% versus 21%) 
(Figure 1). Similar observation for blood pressure (59%), 
overweight (36%) and obesity (39%) were recorded from 
these patients. High concentration of biomarkers for 
HTN and CHD were also recorded for female participants 
attending a cardiac clinic. It was observed that 55% of 
























HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density 
lipoprotein cholesterol; ALT, alanine aminotransferase, CRP, C-
reactive protein. 
Table 3 General characteristics of the study population











Primary level 45 45
Secondary level 32 32
No formal education 9 9
Marital status
Married 73 73











HTN & CHD 12 12
HTN, hypertension; CHD, coronary heart disease.
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female patients had higher levels of HDL-C and CRP 
(>3 mmol/L), respectively. However, 24% of male patients 
were recorded to have abnormal HDL-C (0.90 to <1.15 mmol/
L) and 23% of male patients had more than 3 mmol/L of 
CRP.  Furthermore, more than one-third (37%) and 6% of 
female and male patients had higher ALT levels. 
Association between socio-demographic characteristics, 
lifestyle and intermediate risk factors for HTN and CHDs
Socio-demographic characteristics and lifestyle, as well as 
studied intermediate risk factors, were associated with HTN 
and CHD (Table 4). In this study, gender, HTN, and CHD 
were significantly associated (P≤0.05). Likewise, age showed 
significant association with HTN and CHD (P≤0.001). No 
significant association (P≥0.05) was found between education 
level, occupation with HTN and CHD among patients. 
With the exception of smoking history, which showed 
significant association with HTN and CHD (P≤0.05), 
physical activity, alcohol intake, blood pressure, and BMI 
were not associated with HTN and CHD (Table 4). 
Moreover, blood plasma glucose, serum ALT, serum 
low-density lipoprotein cholesterol (LDL-C), and serum 
CRP were all significantly associated with HTN and CHD 
(P≤0.05) (Table 4).
Determination of independent predictors of HTN among 
patients
Results from Pearson’s chi-square (χ2) showed that gender, 
age, history of smoking, plasma blood glucose, ALT, low-
density lipoprotein, and CRP levels were significantly 
associated with HTN. However, when subjected to 
multinomial logistic regression only age, ALT and glucose 
were independently associated with HTN risk (Table 5) and 
were retained. 
Nevertheless, the association between age and HTN 
was significant, where patients aged <45 years [odds ratio 
(OR) =0.17, 95% CI: 0.047–0.612] were at higher risks of 
HNT than those aged 45 years and above. Patients with 
normal ALT had a lower risk of HTN (OR =3.24, 95% CI: 
1.22–8.57) than those with higher ALT levels. Further 
results showed a significant association between HTN 
and blood sugar, and patients with normal blood sugar 
(OR =0.22, 95% CI: 0.62–0.76) had reduced risk of HTN 
than diabetic patients. 
Determination of independent predictors for CHD among 
patients
As shown in Table 6, the association between CHD risk and 
age were statistically significant (P=0.002). Patients aged 
<45 years were almost four times at high risk of suffering 
from CHD (OR =9.82, 95% CI: 2.37–40.62) compared 
to those aged >45 years. The risk for CHD was higher 
among patients with high ALT levels compared to those 
with normal ALT levels (OR =0.34, 95% CI: 0.12–0.93). 
Patients with high ALT levels were more likely to suffer 
from CHD, contrary to patients with normal blood sugar 
(OR =4.77, 95% CI: 1.31–17.42). Moreover, results showed 
Figure 1 The proportion of risk factors for hypertension and coronary heart diseases in male and female participants. ALT, alanine 
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Table 4 Association between socio-demographic, lifestyle risk factors, and biochemical markers with hypertension and coronary heart diseases 
Variables
Diseases type
χ2 test (P value)
HTN (N=65, 65%) CHD (N=23, 23%) HTN & CHD (N=12, 12%)
Socio-demographics
Gender 0.007*
Males 22 2 7
Females 43 21 5
Age (years) 0.000*
<45 4 15 0
>45 61 8 12
Education level 0.760
HEL 9 3 2
SEC 20 8 4
PR 28 12 5
NE 8 0 1
Occupation 0.614
Formal employment 9 4 2
Self-employed 45 18 9
unemployed 11 1 1
Lifestyle risk factors
Physical activity 0.350
Yes 28 6 5
No 37 17 7
History smoking 0.040*
Yes 10 2 5
No 55 21 7
Alcohol consumption 0.764
Yes 45 14 8
No 20 9 4
Body mass index (BMI) 0.772
18.5–24.9 kg/m2 12 9 4
25.0–29.9 kg/m2 25 7 4
≥30.0 kg/m2 28 7 4
Blood pressure 0.688
Normal 6 8 1
Pre-hypertension 17 6 3
Hypertension stage I 15 2 4
Hypertension stage II 27 7 4
Table 4 (continued)
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that patients with normal CRP (OR =0.25, 95% CI: 
0.08–0.79) had a lower risk for CHD compared to those 
with higher CRP levels. 
Discussion
 
The study provides an overview of the assessment of CVD 
risk factors among diagnosed patients attending the cardiac 
clinic at a referral hospital in Tanzania. Findings showed 
a higher prevalence of HTN and CHD, with a higher 
proportion of patients being exposed to CVD risk factors 
despite the fact that they were under clinical management. 
Risk factors for these diseases were higher among female 
patients than male patients and this has been associated with 
higher number of female patients involved in this study 
69% versus 31% for female and male, respectively. To date, 
there are only two studies population (28,29) conducted in 
Tanzania related to CHD and their associated risk factors. 
These studies have reported a lower prevalence of CHD 
and their associated risk, contrary to the current findings 
which showed a higher prevalence of CHD and their 
associated risk factors. This might be due to the fact that all 
patients who participated in this study had known medical 
conditions (HTN and CHD). Our study cannot rely on 
previous trends since these studies (28,29) were conducted 
in the past two decades. Results from this study reflect the 
current trend of CVDs, which is characterized by changes 




χ2 test (P value)
HTN (N=65, 65%) CHD (N=23, 23%) HTN & CHD (N=12, 12%)
Biochemical markers
Plasma glucose 0.004*
Normal 38 22 9
Hyperglycemia/diabetes 27 1 3
ALT 0.041*
Normal 43 9 5
High risk 22 14 7
LDL-C 0.016*
Normal 24 11 0
High risk 41 12 12
HDL-C 0.066
Normal-males 7 0 0
Normal-females 7 6 1
Moderate-males 8 2 4
Moderate-females 23 10 3
High risk-males 7 0 3
High risk-females 13 5 1
CRP 0.033*
Normal 18 4 0
Moderate risk 12 6 0
High risk 35 13 12
Chi square (χ2) test. Values were statistically significant (*P<0.05), HTN, hypertension; CHD, coronary heart diseases; ALT, alanine 
aminotransferase; CRP, C-reactive protein; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; HEL, 
Higher education learning; SEC, secondary level; PR, primary level; NE, no formal education.
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Saharan countries (30). The current prevalence of HTN 
and CHD is higher compared to 37% and 9% prevalence of 
HTN and CHD, respectively (9). 
This current study showed that 61% of patients did 
not engage in physical exercise for at least 30 minutes 
per week. Our findings, however, are in disagreement 
to that reported by the national STEP survey (31) and 
Ram and Trivedi (32) who found that 96.7% and 92.6% 
of study participants were physically active, respectively. 
Low level of physical activity among patients has been 
related to aging, cardiovascular symptoms and other 
chronic diseases, such as arthritis that reduces walking 
ability. The patients’ general health condition, shortage 
of breath, fatigue, and weakness have been reported 
as factors that lower levels of physical activity among 
patients with CHD (33,34). The percentage of physical 
inactivity observed among patients in this study were also 
inconsistent with other related study findings conducted 
by Stewart et al. (46%) (34), and Press et al. (17%) (33) 
among patients with CHD. 
Regardless of the fact that all patients in this study 
were using drugs for the treatment of HTN and CHD, 
Table 5 Results from multinomial logistic models for significant predictors of hypertension
Variable Parameter estimated (B) Standard error P value OR/Exp. (B) 95% CI of OR
Age (years)
<45 −1.78 0.66 0.007 0.17 0.047–0.612
>45 Reference – – – –
ALT
No risk −1.18 0.49 0.018 3.24 1.22–8.57
Risk Reference – – – –
Glucose 
Normal −1.53 0.64 0.016 0.22 0.62–0.76
Hyperglycemia/diabetes Reference – – – –
ALT, alanine aminotransferase; CRP, C-reactive protein; CI, confidence interval; OR, odds ratio.
Table 6 Results from multinomial logistic models for significant predictors of CHD
Variable Parameter estimated (B) Standard error P value OR/Exp (B) 95% CI of OR
Age (years)
<45 2.28 0.72 0.002 9.82 2.37–40.62
>45 Reference – – – –
ALT
No risk −1.09 0.52 0.035 0.34 0.12–0.93
Risk Reference – – – –
Glucose 
Normal −1.56 0.66 0.018 4.77 1.31–17.42
Hyperglycemia/diabetes Reference – – – –
CRP
Normal −1.38 0.58 0.018 0.25 0.08–0.79
High level Reference – – – –
ALT, alanine aminotransferase; CRP, C-reactive protein; CHD, coronary heart disease; CI, confidence interval; OR, odds ratio.
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the majority (67%) of patients had a current history of 
alcohol intake. Patients with a history of alcohol intake 
were more affected by HTN (45%) and CHD (22%). 
This may be due to the key role played by alcohol in 
influencing atherosclerotic, inflammation and thrombosis 
formation that worsen the diseases condition (35). The 
overall prevalence of alcohol consumption was higher 
compared to that reported by Mbatia et al. (17.2%) (36), 
and by Francis et al. (20% and 22%) (37) in rural and urban 
areas of Tanzania, respectively. A lower level of knowledge 
on alcohol intake to the overall health status, reduction of 
drug efficacy and efficiency has been identified as factors 
that affect treatment progress among patients. This reduces 
the rate of recovery from the diseases and may result in 
more health complications such as heart failure, arterial 
fibrillation, and stroke (38). 
In the present study, a large number of patients were 
overweight and obese, 36% and 39%, respectively. This has 
been related to the lower level of physical activity and poor 
eating habits, characterized by low consumption of fruits 
and vegetables. However, this was contrary to the findings 
from a European survey among patients with CHD, which 
found only 31% of the patients were obese (39). The 
prevalence of overweight and obesity found in this study 
is likely to worsen the health status of patients since it has 
been related to increased risk of CHD (39).
Moreover, the study found that majority of patients 
(59%) had uncontrolled blood pressure levels (systolic 
blood pressure ≥140 mmHg and diastolic blood pressure 
≥90 mmHg), higher than 50% of the CHD patients 
who were found with higher levels of blood pressure 
in EUROASPIRE II Heart Survey Programme (39). 
However, this was almost similar with 57% of hypertensive 
participants (40) and lower compared to the prevalence 
of 37% reported in Dar es Salaam (41). The estimates of 
hypertensive people (10% to 20%) in the Sub-Saharan 
region (42) is lower compared to the current prevalence 
(59%). Higher levels of blood pressure among patients 
were related to higher consumption of dietary salts, which 
increases blood pressure. Dietary salt does not only increase 
blood pressure but also causes endothelial dysfunction, 
albuminuria, and development of kidney disease (43). 
World health organization recommend salt intake 
of <4 g/day among patients with high blood pressure (14). 
A diet low in sodium and increased potassium serves as 
a strategy to reduce blood pressure and decreases CVD 
mortality and morbidity (43). Study conducted in a 
hypertensive unit in Spain found that 42% of the CHD 
patients had attained a targeted goal of lowering blood 
pressure (<140 mmHg systolic and <90 mmHg diastolic) 
after management (44). Patients should be encouraged 
to reduce salt intake and dietary sodium and increases 
consumption of dietary potassium which can be achieved by 
eating legumes and a variety of fruits and vegetables (14). 
More education is thus needed in Tanzania when managing 
patients with HTN, especially on the importance of 
reducing salt intake, to meet the required target of blood 
pressure among the patients.
Diabetes is one of the important risk factors for the 
development of CVD (16). One-third of patients in 
the current study had uncontrolled plasma blood sugar, 
compared to 87% of the patients with higher (>6 mmol/L) 
plasma glucose reported in EUROASPIRE II Heart Survey 
Programme (39). The proportion of male (11%) and female 
(22%) patients with higher plasma glucose was lower 
compared to 15.3% of men and 23.2% of women reported 
from 14 clinical trials data (45). The overall prevalence of 
diabetes in the current study was higher compared to 21.7% 
reported in Kilimanjaro region by Stanifer et al. (46), and 5% 
and 2% found in urban and rural Tanzania, respectively (47). 
Patients with higher plasma glucose have also an increased 
risk of heart diseases and stroke due to insulin resistance (48). 
Higher levels of ALT were recorded among study 
patients in this study. Higher levels of ALT are related to 
alcohol consumption, insulin resistance, obesity and other 
chronic diseases such as renal diseases (49). The present 
findings were similar with other reported in the cross-
sectional analysis conducted in the United States (49), of 
which 267 CHD patients had >42 IU/L ALT levels. The 
present findings are contrary to 12% of patients found 
with higher ALT concentration in a study conducted in 
a primary care setting in central Virginia from 2010 to 
2011 (50). Elevated ALT levels trigger the formation of 
atherosclerotic plaques, and it has been demonstrated that 
changes in lifestyle, as well as the use of lipid-lowering 
drugs, can return ALT levels to normal (51). The current 
study showed a significant association between higher 
ALT levels, HTN and CHD. Patients with a higher 
concentration of ALT had a higher risk for HTN and 
CHD than patients with normal ALT levels. Studies 
have found that patients with a higher concentration 
of ALT were more likely to be hypertensive and suffer 
from CHD than patients with normal ALT levels (52). 
High ALT levels were recognized as an independent 
predictor of CHD risk factors (49,53), similar to what 
was observed in the current study. Additionally, ALT has 
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been associated with angiographic atherosclerosis score in 
women independently of metabolic syndrome and serum 
CRP concentration (51). 
Higher CRP levels have been identified as a predictive 
marker for MI, stroke, and sudden cardiac death both 
health individual and in patients with stable CHD (22). 
CRP is produced in the presence of inflammation, infection 
and tissue damage (54). Uncontrolled HTN observed 
among patients has been related to increased CRP levels, as 
it causes damage to arteries (14). More than three-quarter 
of the study patients (78%) in this study were found with 
higher CRP levels, and the burden of HTN and CHD 
among these patients increased with increased CRP levels. 
Similar findings were reported in a Framingham Heart 
Study, which revealed 260 CHD patients with higher CRP 
levels (55). Similarly, the Hisayama Study (56) showed 
129 CHD patients with >3 mg/L of CRP in the general 
population of Japanese. Higher levels of CRP have been 
associated with conventional risk factors for both ischemic 
vascular and non-vascular diseases (57). In our study, CRP 
was positively associated with CHD, this is similar with 
findings from the epidemiological data that showed an 
association between higher CRP levels and future CVD 
morbidity among those patients with known CHD (58). 
Other studies have also revealed the association between 
higher CRP levels and increased CHD events both among 
patients with known and unknown CHD (59,60). However, 
this was contrary to Casas et al. (61) who reported an 
insignificant association between CRP and CVD events 
including CHD. 
The severity of CHD has been recognized to increase 
with aging (62), and it independently predicts CHD 
risk factors. In the current study, age was found to be an 
independent risk factor for CHD, and those patients aged 
<45 had higher CHD risk than elderly people, which was 
also contrary to other documented studies in developed 
countries, which showed decreased CHD mortality and 
morbidity among younger age groups (63). This might be 
affected by a small number of patients participated in the 
present study. Pal and Grera (64), also showed higher CHD 
risk factors among patients aged >50 years.
Results from this study also showed a significant 
association between plasma glucose, HNT, and CHD, 
which is similar with other study findings which showed a 
significant association between diabetes and risk factors for 
CVD, especially CHD (65). Additionally, current findings 
were similar to other reported studies which showed a 
significant association between diabetes and increased CVD 
risk factors (47,66).
This study had the following limitations; Limited time 
frame and financial resources that limited selection of a large 
number of participants. However, despite these constraints, 
obtained results from this study can still be used in the 
monitoring and evaluation of CVD disease management 
progression in other hospital settings in Tanzania.
Conclusions 
This current study revealed a higher prevalence of both 
lifestyle and intermediate risk factors for HTN and CHD 
among clinically managed patients from a referral hospital 
in Tanzania. This indicates inadequate management of these 
risk factors among patients visiting the cardiac clinic. Poor 
management and monitoring of these risk factors can delay 
treatment outcome and cause more health complications, 
which will pose more health cost to the patients. These 
patients should be well educated on lifestyle modification, 
especially on healthy dietary habits and need for increased 
physical activity. Patients should also be well encouraged 
to reduce the amount of salt to the recommended levels 
(<5 g/day), for lowering blood pressure. This study further 
demonstrated the key role played by inflammatory markers 
particularly CRP and ALT in determining CVDs risk. This 
study highlights the need for further mechanic studies on 
determining how inflammatory markers (CRP and ALT) 
are involved with the pathogenesis of CHDs in this cohort 
of patients. 
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